Clinical Trial Update

Category
Continent
From
To
 
Mapi Pharma Reports Positive Phase I/IIa Results f...

Mapi Pharma Reports Positive Phase I/IIa Results f...

Category : Clinical Trial Update 13 August 2026

Long-Acting Injectable Cariprazine Shows Encouraging Safety Results Mapi Pharma Ltd. has announce...
ArkBio Receives China IND Approval for Long-Acting...

ArkBio Receives China IND Approval for Long-Acting...

Category : Clinical Trial Update 13 August 2026

AK0406 Becomes First Influenza AFC Candidate to Enter Clinical Development in China Shanghai Ark...
Ascletis Starts Phase 1 Trials for Once-Monthly Ob...

Ascletis Starts Phase 1 Trials for Once-Monthly Ob...

Category : Clinical Trial Update 11 August 2026

Company Advances Two Long-Acting Obesity Drug Candidates in the US Ascletis has started two Phase...
Kodiak Sciences Starts Phase 3 ALTO Trial of KSI-5...

Kodiak Sciences Starts Phase 3 ALTO Trial of KSI-5...

Category : Clinical Trial Update 11 August 2026

Global Study Begins to Test a Dual-Target Retinal Therapy Kodiak Sciences Inc. has started enroll...
Kodiak Sciences Completes First 300-Patient Enroll...

Kodiak Sciences Completes First 300-Patient Enroll...

Category : Clinical Trial Update 10 August 2026

Topline Data from Pivotal Analysis 1 Expected in December 2026 Kodiak Sciences Inc., a biotechnol...

Categories

Latest Newsletter Post

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!